Publications by authors named "Martin Vostry"

Patients with myelodysplastic neoplasms (MDS) are classified according to the risk of acute myeloid leukemia transformation. Some lower-risk MDS patients (LR-MDS) progress rapidly despite expected good prognosis. Using diagnostic samples, we aimed to uncover the mechanisms of this accelerated progression at the transcriptome level.

View Article and Find Full Text PDF

Objective: Somatic mutations in UBA1 have recently been causally linked to a severe adult-onset inflammatory condition referred to as VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome. Ubiquitin-activating enzyme E1 (UBA-1) is of fundamental importance to the modulation of ubiquitin homeostasis and to the majority of downstream ubiquitylation-dependent cellular processes. Direct sequencing analysis of exon 3 containing the prevalent variants p.

View Article and Find Full Text PDF

Deferasirox (DFX) is an oral iron chelator used to reduce iron overload (IO) caused by frequent blood cell transfusions in anemic myelodysplastic syndrome (MDS) patients. To study the molecular mechanisms by which DFX improves outcome in MDS, we analyzed the global gene expression in untreated MDS patients and those who were given DFX treatment. The gene expression profiles of bone marrow CD34 cells were assessed by whole-genome microarrays.

View Article and Find Full Text PDF

Radix lagotis is an intermediate snail host of the nasal bird schistosome Trichobilharzia regenti. Changes in defence responses in infected snails that might be related to host-parasite compatibility are not known. This study therefore aimed to characterize R.

View Article and Find Full Text PDF
Article Synopsis
  • Downregulation of the CRBN gene is linked to lenalidomide resistance and poor outcomes in multiple myeloma patients, but its role in myelodysplastic syndrome (MDS) remains unclear.
  • This study examined CRBN expression in bone marrow and peripheral blood from various MDS patients and healthy controls, revealing that patients with 5q deletion (5q-) exhibited the highest CRBN mRNA levels.
  • High CRBN levels were found in patients who responded well to lenalidomide, while decreased levels during treatment were associated with loss of response and disease progression, indicating CRBN's importance for the drug's effectiveness in MDS.
View Article and Find Full Text PDF

Background: Studying DNA methylation changes in the context of structural rearrangements and point mutations as well as gene expression changes enables the identification of genes that are important for disease onset and progression in different subtypes of acute myeloid leukemia (AML) patients. The aim of this study was to identify differentially methylated genes with potential impact on AML pathogenesis based on the correlation of methylation and expression data.

Methods: The primary method of studying DNA methylation changes was targeted bisulfite sequencing capturing approximately 84 megabases (Mb) of the genome in 14 diagnostic AML patients and a healthy donors' CD34+ pool.

View Article and Find Full Text PDF

Friend leukemia virus integration 1 (Fli1) and erythroid Krüppel-like factor (EKLF) participate under experimental conditions in the differentiation of megakaryocytic and erythroid progenitor in cooperation with other transcription factors, cytokines, cytokine receptors, and microRNAs. Defective erythropoiesis with refractory anemia and effective megakaryopoiesis with normal or increased platelet count is typical for 5q- syndrome. We decided to evaluate the roles of EKLF and Fli1 in the pathogenesis of this syndrome and of another ribosomopathy, Diamond-Blackfan anemia (DBA).

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Martin Vostry"

  • - Martin Vostry's research primarily focuses on hematological disorders, particularly myelodysplastic syndromes (MDS) and related conditions, exploring molecular mechanisms underlying disease progression and treatment efficacy.
  • - His recent articles highlight the identification of transcriptome signatures in lower-risk MDS patients, novel genetic variants linked to inflammatory conditions, and the impact of treatments like deferasirox on immune responses in MDS patients.
  • - Vostry also investigates the roles of specific genes and transcription factors in blood cell differentiation and their implications for therapies, shedding light on the complexities of disease mechanisms involving both genetic and epigenetic factors.